UY26833A1 - USE OF PARAPOXVIRUS OVIS VAPES AGAINST ORGAN FIBROSIS - Google Patents
USE OF PARAPOXVIRUS OVIS VAPES AGAINST ORGAN FIBROSISInfo
- Publication number
- UY26833A1 UY26833A1 UY26833A UY26833A UY26833A1 UY 26833 A1 UY26833 A1 UY 26833A1 UY 26833 A UY26833 A UY 26833A UY 26833 A UY26833 A UY 26833A UY 26833 A1 UY26833 A1 UY 26833A1
- Authority
- UY
- Uruguay
- Prior art keywords
- vapes
- liver
- organ fibrosis
- parapoxvirus ovis
- against organ
- Prior art date
Links
- 241000700639 Parapoxvirus Species 0.000 title abstract 2
- 206010016654 Fibrosis Diseases 0.000 title 1
- 241000283898 Ovis Species 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 201000003883 Cystic fibrosis Diseases 0.000 abstract 1
- 206010019799 Hepatitis viral Diseases 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 208000019423 liver disease Diseases 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 201000001862 viral hepatitis Diseases 0.000 abstract 1
- 210000001835 viscera Anatomy 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere al uso en humanos de parapoxvirus inactivos en la profilaxis y tratamiento de enfermedades que están acompanadas por un aumento de la concreción de colágeno, pudiendo concernir tanto a órganos internos, como por ejemplo el hígado, como también a la piel y sus anexos. Se refiere especialmente a fibrosis hepática o cirrosis hepática como consecuencia de hepatitis viral o enfermedades hepáticas inducidas por etanol, así como fibrosis quística.The present invention relates to the use in humans of inactive parapoxviruses in the prophylaxis and treatment of diseases that are accompanied by an increase in collagen concretion, being able to concern both internal organs, such as the liver, as well as the skin and its annexes. It especially refers to liver fibrosis or liver cirrhosis as a result of viral hepatitis or ethanol-induced liver diseases, as well as cystic fibrosis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY26833A UY26833A1 (en) | 2001-07-11 | 2001-07-11 | USE OF PARAPOXVIRUS OVIS VAPES AGAINST ORGAN FIBROSIS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY26833A UY26833A1 (en) | 2001-07-11 | 2001-07-11 | USE OF PARAPOXVIRUS OVIS VAPES AGAINST ORGAN FIBROSIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY26833A1 true UY26833A1 (en) | 2002-01-31 |
Family
ID=38812466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY26833A UY26833A1 (en) | 2001-07-11 | 2001-07-11 | USE OF PARAPOXVIRUS OVIS VAPES AGAINST ORGAN FIBROSIS |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY26833A1 (en) |
-
2001
- 2001-07-11 UY UY26833A patent/UY26833A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074824L (en) | Extension of time to disease progression or survival in cancer patients | |
| SG163517A1 (en) | Antiviral compounds and methods | |
| MX2010003916A (en) | Spiropyrrolidines and their use against hcv and hiv infection. | |
| CY1111050T1 (en) | PHOSPHONES, MONO-PHOSPHONAMIDES, BISPHOSPHONAMIDES FOR THE TREATMENT OF VIRUS DISEASES | |
| WO2007081517A3 (en) | Anti-viral compounds | |
| NO20074361L (en) | Lacosamide for "add-on" therapy | |
| NO20085243L (en) | Pharmaceutical composition for the treatment of viral infections and / or tumor diseases through inhibition of protein folding and protein degradation | |
| BR0208142A (en) | Combinations comprising an antidiarrheal agent and epothilone or epothilone derivative | |
| ITMI20041550A1 (en) | USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS | |
| CY1110437T1 (en) | USE OF KASTANOSPERMIN PRODUCTS FOR THE TREATMENT OF USITIS C | |
| MY137766A (en) | Exemestane as chemopreventing agent | |
| NO20055130D0 (en) | Aminocyclohexyl ether compounds and their use | |
| DE60330708D1 (en) | VACCINE AGAINST WEST NILE VIRUS | |
| PE20081215A1 (en) | IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICATION VARIANTS WITH LOWER SUSCEPTIBILITY TO HCV-796, AND RELATED METHODS | |
| AR028800A1 (en) | USE OF PARAPOXVIRUS OVIS VAPES AGAINST ORGAN FIBROSIS | |
| NO20076405L (en) | Use of 24-nor-UDCA | |
| BR0108499A (en) | Hepatitis c therapeutic agent | |
| UA85379C2 (en) | Recombinant poxvirus, comprising at least two ati promotors of cowpox | |
| HK1054329A1 (en) | Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer | |
| GT200600262A (en) | USE OF SANGLIFERINE IN HCV (HEPATITIS VIRUS "C") | |
| MXPA02011969A (en) | Methods of treating viral diseases with il-18 and il-18 combinations. | |
| UY27827A1 (en) | COMPOSITIONS AND THERAPEUTIC USE | |
| UY26833A1 (en) | USE OF PARAPOXVIRUS OVIS VAPES AGAINST ORGAN FIBROSIS | |
| IL164179A0 (en) | Expression of genes in modified vaccinia virus ankara by using the cowpox ati promoter | |
| TW200716226A (en) | Compositions comprising actinidia and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20141021 |